Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma Limited has submitted copies of newspaper advertisements publishing its financial results for the fourth quarter and the financial year ended March 31, 2026. The results were published in Business Standard (English) and Nava Telangana (regional language) on May 23, 2026. The company secretary, B. Adi Reddy, submitted this filing on behalf of the company to both NSE and BSE on the same date. This is a routine regulatory compliance filing to formally record the newspaper publication of quarterly and annual results in the public domain.
No new material information is contained in this filing — it merely confirms that audited financial results were publicly disclosed. Shareholders and analysts should refer to the actual newspaper advertisements for Q4/FY26 numbers to assess company performance.